Reuters logo
BRIEF-Suda ‍To Buy Global Intellectual Property Relating To Anagrelide
November 28, 2017 / 2:06 AM / 14 days ago

BRIEF-Suda ‍To Buy Global Intellectual Property Relating To Anagrelide

Nov 28 (Reuters) - Suda Ltd:

* ‍TO BUY GLOBAL INTELLECTUAL PROPERTY RELATING TO ANAGRELIDE, THAT HAS RECENTLY SHOWN PROMISE AS A NOVEL ANTI- CANCER AGENT​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below